Applications Published 14 March 2001
Published: 20-Dec-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Use of micro-organism extracts in cosmetic or pharmaceutical compsns
Pierre Fabre Dermo-Cosmetics 1082091*Anti-germ attachment compsn
Colgate-Palmolive Company 1082092*Skin cleansing compsn providing enhanced perfumed deposition
Colgate-Palmolive Company 1082094*N-oxide of heterocyclic ester, amide, thioester or ketone hair growth compsns and uses
GPI NIL Holdings 1082095*Skin treatment compsns and the use thereof
Natural ASA 1082096*Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism
Institut Francais du Petrole; Sophor 1082097*Cosmetic treatment method for fighting against skin ageing effects
Guerlain 1082098*Cosmetic or dermatologic preparations containing catechins or green tea extract
Beiersdorf 1082100*Biologicall active compsn
Bioglan 1082102*Spill resistant pharmaceutical compsns
Taro Pharmaceutical 1082103*Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compsns containing them
Virsol 1082104*Controlled drug delivery system using the conjugation of drug to biodegradable polyester
Mogam Biotechnology Research Institute 1082105*Sublingual buccal effervescent
Cima Labs 1082106*Controlled release lipoic acid
Medical Research Institute 1082107*Improvements in medicaments for asthma treatment
Britannia Pharmaceuticals 1082108*Oral formulation comprising biguanide and an organic acid
Sumitomo Pharmaceuticals 1082109*Use of compounds for the elevation of pyruvate dehydrogenase activity
AstraZeneca 1082110*Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
Galderma Research and Development 1082111*Endogenous nitric oxide synthesis under conditions of low oxygen tension
Nitromed 1082112*Compsns and methods for alleiviating impaired memory function, memory loss and reducing recovery time in anaesthetised mammals
Carlen, Peter Louis 1082113*Hydroxyomeprazole compsns and uses
Sepracor 1082114*Heterocyclic cis cyclopropane derivatives as melatonergic agents
Bristol-Myers Squibb 1082115*Use of 4-piperidinemethanol derivatives in the treatment of neurodevelopmental disorders
A Carlsson Research 1082116*A stabilised antihistamine syrup containing aminopolycarboxylic acid as stabiliser
Schering Corp 1082117*Mehod for the normalisation of sexual response and amelioration of long-term genital tissue degradation
Queen's University at Kingston 1082118*Microemulsion preconcentrates containing a piperidine substance P antagonist
Novartis 1082119*Pyrrolo[2,3D]pyrimidine compsns and their uses
OSI Pharmaceuticals 1082120*HIV integrase inhibitors
Merck; Tularik 1082121*Isolflavonoids for treatment and prevention of migraine headaches
Gorbach, Sherwood L 1082122*Use of a nucleic acid-binding chemotherapeutic agent, and a pharmaceutical compsn
Faculteit Geneeskunde Universiteit Utrecht 1082123*Pharmaceutical or cosmetic compsn and method for cosmetic treatment of angiogenic disorders
Pierre Fabre Dermo-Cosmetique 1082125*Novel peptides
Hadasit Medical Research Services and Development 1082126*Succinimide inhibitors of interleukin-1g(B) converting enzyme
Warner-Lambert; BASF 1082127*Lysine containing peptides for treatment of heart disease.
Deghenghi, Romano 1082128*Method for the treatment of fertility disorders
Asta Medica 1082129*Use of cyclosporins in the treatment of inflammatory autoimmune diseases
Novartis 1082130*Immunoregulator
Erasmus University Rotterdam 1082131*Recombinant human interferon beta-1A (IFN-beta-1A) formulation
Biogen 1082132*Pharmaceutical formulations for IGF/IGFBP
Celtrix Pharmaceuticals 1082133*Compsn comrpising tumour cells and extracts and method of using thereof
Thomas Jefferson University 1082134*Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
Chiron Corp 1082135*The cytokine family member, 2-19
SmithKline Beecham 1082136*Reversal of proinflammatory response by ligating the macrophage FCg(G)RI receptor
Temple University of the Commonealth System of Higher Education 1082137*Texaphin conjugates and uses thereof
Board of Regents of the University of Texas System; Pharmacyclics 1082138*Carrier for in vivo delivery of a therapeutic agent
University of Medicine and Dentistry of New Jersey 1082139*Gene expression method
University of Pittsburgh of the Commonwealth System of Higher Education 1082140*CD40 binding molecules and CTL peptides for treating tumours
Leiden University Medical Centre 1082141*Compsns and methods for delivery of genetic material, for altering neuronal growth, regeneration, and survival
Selective Genetics 1082142*MR signal-emitting coatings
Wisconsin Alumni Research Foundation 1082143*Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or alpha-keto esters
Firmenich 1082287*Process for preparing paraphenylenediamine derivatives
Uniroyal Chemical 1082288*Methods for identifying novel multimeric agents that modulate receptors
Advanced Medicine 1082289*Process for the preparation of aceclofenac
Russinsky 1082290*Chemical process for the stereoselective synthesis of R-(-)-carnitine
Sigma-Tau Industrie Farmaceutiche Riunite 1082291*Control of pain with endogenous cannabinoids
Neurosciences Research Foundation 1082292*Formoterol polymorphs
Sepracor 1082293*Phenylalanine derivatives as integrin inhibitors
Celltech Therapeutics 1082294*Substituted 4-biarylbutyric and biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
Bayer 1082295*Stabilisation of organic polyisocyanates
Bayer 1082296*Substituted dithio-bis-nitrobenzenes and their applications
Institut Pasteur de Lille; Centre National de la Recherche Scientifique 1082297*!g(A)-hydroxy-25-ene-vitamin D, analogues and uses thereof
Bone Care International 1082298*C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
Procter & Gamble 1082299*3-[(1'-N-methylamino)ethyl-N-benzyl]pyrrolidine monomethanesulfonate
Pharmacia & Upjohn 1082300*Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isoesters
GPI NIL 1082301*A VLA-4 inhibitor: Omepupa-V
Biogen 1082302*Heterocyclic derivatives which inhibit factor XA
AstraZeneca 1082303*New crystalline polymorphic form of 1-methyl-5-P-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester (med 15)
Sigma-Tau Industrie Farmaceutische Riunite 1082304*Pyrrole substituted 2-indolinone protein kinase inhibitors
Sugen 1082305*Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
Warner-Lambert 1082306*Processes and intermediates for preparing 2-substituted piperidine stereoisomers
Celgene Corp 1082307*Heterocyclically substituted amides used as calpain inhibitors
BASF 1082308*Process for the preparation of a 3(2H)-pyridazinone-4-substituted amin0-5-chloro-derivative
Egis Gyogyszergyar 1082309*Methods of identifying and using HLA binding compounds as HLA-agonists and antagonists
Georgetown University 1082310*Quinazolines for treating brain tumours
Parker Hughes Institute 1082311*Sulfonyl amino (thio)carbonyl triazoline (thi)ons having alkenyl substituents
Bayer 1082312*Bicyclic compounds, process for their preparation and pharmaceutical compsns containing them
Dr Reddy's Research Foundation 1082313*New dipeptidyl peptidase IV effectors
Probiodrug Gesellschsft fuer Arzneimittelforschung 1082314*Potassium channel inhibitors
Icagen; Eli Lilly 1082315*Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-CBZ baccatin III
Napro Biotherapeutics 1082316*Method for producing phthalic anhydride by means of catalytic vapour phase oxidation of oxylol/naphthalene mixtures
BASF 1082317*Thiacrown ether compound
BetzDearborn 1082318*Benzocarbazol and indenoinole derived estrogenic agents.
American Home Products 1082319*Novel substituted imidazole compounds
SmithKline Beecham 1082320*Heterocyclic derivatives which inhibit factor XA
AstraZeneca 1082321*Oxazolidinone derivatives, process for their preparation and pharmaceutical compsns containing them
AstraZeneca 1082322*Oxazolidinone derivatives, process for preparing them and pharmaceutical compsns containing them
AstraZeneca 1082323*Imidazopyridine thrombin inhibitors
Merck 1082324*Naphthosulphamylmethyl penem antibacterials
Merck 1082325*Cephalosporins having cyclic aminoguanidine substituents as antibiotics
Biochemie 1082326*Perfluorinated organo substituted cylcosiloxanes and copolymers prepared from these cyclosiloxanes
Archimica (Florida) 1082327*Production of optically active phospholanes
BASF 1082328*Platinum complex, its preparation and therapeutic application
Pliva-Lachema 1082329*Platinum complex, its preparation and therapeutic application
Pliva-Lachema 1082330*Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
Korea Institute of Science and Technology; Il-Yang Pharm 1082331*Silica-guanidiniumthiocyanate DNA isolation doing casein
Academische Ziekenhuis bij de Universiteit van Amsterdam 1082332*Thiocolchicoside derivative, preparation and therapeutic application
Sanofi-Synthelabo 1082333*ALG-2LP, ALG-2-like molecules and uses therefore
Millennium Pharmaceuticals 1082334*Novel secreted and membrane-associated proteins and uses therefore
Millennium Pharmaceuticals 1082335*Apoptosis modulators that interact with the Huntington's disease gene
University of British Columbia 1082336*17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
Research Triangle Institute 1082337*17-beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
Research Triangle Institute 1082338*Rationally designed peptides, production and use thereof
Affina Immuntechnik 1082339*Peptide vaccine for canine allergy
Idexx Laboratories 1082340*Tumour antigen useful in diagnosis and therapy of prostate and colon cancer Urogenesys; Mitchell, Stephen
Chappell 1082341*Vaccine for Pseudomonas aeruginosa
The Governers of the University of Alberta 1082342*Toxoplasma gondii antigens, P35, and uses thereof
Aboot Laboratories 1082343*Glycoproteins having lipid mobilising properties and cations thereof
Tisdale, Michael John 1082344*Method of designing agonists and antagonists to EGF receptor family
Biomolecular Research Institute 1082345*Specific binding proteins for treating canine allergy
Idexx Laboratories 1082346*
